[1]
|
K. Ranganathan and R. Hemalatha, “Oral Lesions in HIV Infections in Developing Countries: An overview,” Advances in Dental Research, Vol. 19, No. 1, 2006, pp. 63-68. doi:10.1177/154407370601900113
|
[2]
|
J. L. Ziegler and E. Katongole-Mbidde, “Kaposi’s Sarcoma in Childhood: An Analysis of 100 Cases from Uganda and Relationship to HIV Infection,” International Journal of Cancer, Vol. 65, No. 2, 1996, pp. 200-203.
doi:10.1002/(SICI)1097-0215(19960117)65:2<200::AID-IJC12>3.0.CO;2-H
|
[3]
|
L. Feller and J. Lemmer, “HIV-Associated Kaposi’s Sarcoma: Pathogenic Mechanisms,” Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics, Vol. 104, No. 4, 2007, pp. 521-529.
doi:10.1016/j.tripleo.2006.08.015
|
[4]
|
K. P. Manji, H. Amir and I. Z. Maduhu, “Aggressive Kaposi’s Sarcoma in a 6-Month-Old African Infant: Case Report and Review of the Literature,” Tropical Medicine & International Health, Vol. 5, No 2, 2000, pp. 85-87.
doi:10.1046/j.1365-3156.2000.00523.x
|
[5]
|
A. K. Agarwal, G. Zamzachin, Y.Mohen, M. Y. Singh and N. Singh, “AIDS Related Kaposi’s Sarcoma—Like Lesion,” Indian Journal of Dermatology, Vol. 62, No. 2, 1996, pp. 129-131.
|
[6]
|
J. B. Epstein, R. J. Cabey and M. Glick, “Oral Malignancies in HIV Disease: Changes in Disease Presentation, Increasing Understanding of Molecular Pathogenesis and Current Management,” Oral Surgery Oral Medicine Oral Pathology Oral Radiology, and Endodontics, Vol. 100, No. 5, 2005, pp. 571-578.
doi:10.1016/j.tripleo.2005.01.015
|
[7]
|
P. Khongkunthlan, M.Grote, W. Isaratanan, S. Plyaworawong and P. A. Reichart, “Oral Manifestations in 45 HIV-Positive Children from Northern Thailand,” Journal of Oral Pathology & Medicine, Vol. 30, No. 9, 2001, pp. 549-552. doi:10.1034/j.1600-0714.2001.300907.x
|
[8]
|
I. D. Miziara, B. C. Araújo Filho and R. Weber, “Oral Lesions in Brazilian HIV-Infected Children Undergoing HAART,” International Journal of Pediatric Otorhinolaryngology, Vol. 70, No. 6, 2006, pp. 1089-1096. doi:10.1016/j.ijporl.2005.11.010
|
[9]
|
I. Lager, M. Altini, H. Coleman and H. Ali, “Oral Kaposi’s Sarcoma: A Clinicopathologic Study from South Africa,” Oral Surgery Oral Medicine Oral Pathology Oral Radiology, and Endodontics, Vol. 96, No. 6, 2003, pp. 701-710. doi:10.1016/S1079-2104(03)00370-6
|
[10]
|
M. M. Taylor, B. B. Chohan, L. Lavreys, W. Hassan, M. L. Huang, L. Corey, R. Ashley Morrow, B. A. Richardson, K. Mandaliya, J. Ndinya-Achola, J. Bwayo and J. Kreiss, “Shedding of Human HerpesVvirus 8 in Oral and Genital Secretions from HIV-1 Seropositive and Seronegative Kenyan Women,” Journal of Infectious Diseases, Vol. 190, No. 3, 2004, pp. 484-488. doi:10.1086/421466
|
[11]
|
B. Rohrmus, E. M. Thoma-Greber, M. Rocken and J. R. Bogner, “Outlook in Oral and Cutaneous Kaposi’s Sarcoma,” Lancet, Vol. 356, No. 9248, 2000, p. 2160.
doi:10.1016/S0140-6736(00)03503-0
|
[12]
|
A. E. Friedman-Kien, L J. Laubenstein, P. Rubinstein, E. Buimovici-Klein, M. Marmor, R. Stahl, I. Spigland, K. S. Kim and S. Zolla-Pazner, “Disseminated Kaposi’s Sarcoma in Homosexual Men,” Annals of internal medicine, Vol. 96, No. 6, 1982, pp. 693-700.
|
[13]
|
P. C. Windle-Taylor and N. Shah, “Oropharyngeal Kaposi’s Sarcoma: Report of Two Cases and Review of the Literature,” Journal of Laryngology and Otology, Vol. 97, No. 11, 1993, pp. 1065-1071.
|
[14]
|
C. Oji and F. Chukwuneke, “Clinical Evaluation of Kaposi Sarcoma in HIV/AIDS Patients with Orofacial Lesions in Enugu, Nigeria,” Journal of Oral Maxillofacial Surgery, Vol. 66, No. 7, 2008, pp. 1362-1365.
doi:10.1016/j.joms.2007.08.049
|
[15]
|
M. I. Adurogbangba, G. A. Aderinokun, G. N. Odaibo, O. D. Olaleye and T. O. Lawoyin, “Oro-Facial Lesions and CD4 Counts Associated with HIV/AIDS in an Adult Population in Oyo State, Nigeria,” Oral Diseases, Vol. 10, No. 6, 2004, pp. 319-326.
doi:10.1111/j.1601-0825.2004.01036.x
|
[16]
|
G. A. Agbelusi and A. A. Wright, “Oral Lesions as Indicators of HIV Infection among Routine Dental Patients in Lagos, Nigeria,” Oral Diseases, Vol. 11, No. 8, 2005, pp. 370-373.
|
[17]
|
Federal Ministry of Health of Nigeria, “National Guidelines on Cancer Chemotherapy,” Federal Ministry of Health of Nigeria, 2008.
|
[18]
|
N. Mbah, I. H. Abdulkareem and A. Panti, “AIDS-Associated Kaposi’s Sarcoma in Sokoto, Nigeria,” Nigerian Journal of Clinical Practice, Vol. 11, No. 3, 2008, pp. 181-184.
|
[19]
|
D. C. Stefan, D. K. Stones, L. Wainwright and R. Newton, “Kaposi Sarcoma in South African Children,” Pediatric Blood Cancer, Vol. 56, No. 3, 2011, pp. 392-396.
doi:10.1002/pbc.22903
|
[20]
|
A. Mosam, J. Aboobaker and F. Shaik, “Kaposi’s Sarcoma in Sub-Saharan Africa: A Current Perspective,” Current Opinion in Infectious Diseases, Vol. 23, 2010, pp. 119-123.
|
[21]
|
S. Theron, S. Andronikou, R. George, J. du Plessis, P. Goussard, M. Hayes, A. Mapukata and R. Gie, “Non-Infective Pulmonary Disease in HIV-Positive Children,” Pediatric Radiology, Vol. 39, No. 6, 2009, pp. 555-564. doi:10.1007/s00247-009-1156-2
|
[22]
|
C. Okunseri, V. Badner, A. Wiznia and M. Rosemberg, “Prevalence of Oral lesions and Percent CD41+ T-Lym- Phocytes in HIV Infected Children on Antiretroviral Therapy,” AIDS Patient Care and STDS, Vol. 17, No. 1, 2003, pp. 5-11. doi:10.1089/108729103321042863
|
[23]
|
A. Chan, A. Milnes, S. M. King and S. Read, “The Relationship of Oral Manifestations to Parameters of Immune Function and CDC Stage in Children Born to HIV Positive Women,” In: Pediatric AIDS and HIV Infection: Fetus to Adolescent, Williams & Wilkins, Baltimore, 1994, pp. 101-107.
|
[24]
|
B. Ensoli, R. Gendelman, P. Markham, V. Fiorelli, S. Colombini, M. Raffeld, A. Cafero, H. K. Chang, J. N. Brady and R. C. Gallo, “Synergy between Basic Fibroblast Growth Factor and HIV-1 Tat Protein in Induction of Kaposi’s Sarcoma,” Nature, Vol. 371, 1994, pp. 674-680. doi:10.1038/371674a0
|
[25]
|
M. W. Kline, “Oral Manifestations of Pediatric Human Immunodeficiency Virus Infection: A Review of the Literature,” Pediatrics, Vol. 97, No. 3, 1996, pp. 380-388.
|
[26]
|
J. A. Sparano, X. Hu, P. H. Wiernik, C. Sarta, D. M. Reddy, L. Hanau and D. H. Henry, “Opportunistic Infection and Immunologic Function in Patients with Human Immunodeficiency Virus-Associated Non-Hodgkin’s Lymphoma Treated with Chemotherapy,” Journal of the National Cancer Institute, Vol. 89, No. 4, 1997, pp. 301-307. doi:10.1093/jnci/89.4.301
|
[27]
|
A. Plettenberg, U. van Dyk, A. Stoehr, H. Albrecht, H. J. Stellbrink, J. Berger and W. Meigel, “Increased Risk for Opportunistic Infections during Chemotherapy in HIV-In- fected Patients with Kaposi’s Sarcoma,” Dermatology, Vol. 194, No. 3, 1997, pp. 234-237.
doi:10.1159/000246109
|
[28]
|
D. M. Murdoch, W. D. Venter, C. Feldman and A. Van Rie, “Incidence and Risk Factors for the Immune Reconstitution Inflammatory Syndrome in HIV Patients in South Africa: A Prospective Study,” AIDS, Vol. 22, No. 5, 2008, pp. 601-610. doi:10.1097/QAD.0b013e3282f4a607
|
[29]
|
E. Letang, J. Almeida, E. Ayala, I. E. White, C. Carrilho, R. Bastos, T. Nhampossa, C. Menéndez, T. B. Campbell, P. L. Alonso, D. Naniche, “Predictors of Immune Reconstitution Inflammatory Syndrome-Associated with Kaposi Sarcoma in Mozambique: A Prospective Study,” Journal of Acquired Immune Deficiency Syndrome, Vol. 53, No. 5, 2010, pp. 589-597.
|